{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T10:35:19Z","timestamp":1711967719807},"reference-count":36,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.8914-17","type":"journal-article","created":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T22:08:52Z","timestamp":1506290932000},"page":"2827-2836","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of the CHADS&lt;sub&gt;2&lt;\/sub&gt;, CHA&lt;sub&gt;2&lt;\/sub&gt;DS&lt;sub&gt;2&lt;\/sub&gt;-VASc and R&lt;sub&gt;2&lt;\/sub&gt;CHADS&lt;sub&gt;2&lt;\/sub&gt; Scores in Japanese Patients with Non-valvular Paroxysmal Atrial Fibrillation Not Receiving Anticoagulation Therapy"],"prefix":"10.2169","volume":"56","author":[{"given":"Reisuke","family":"Yoshizawa","sequence":"first","affiliation":[{"name":"Division of Cardiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusanori","family":"Kunugita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahito","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingen","family":"Ohwada","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Satoh","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Morino","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Ohsawa M, Okayama A, Sakata K, et al. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular disease in 1980, 1990 and 2000. J Epidemiol 15: 194-196, 2005."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular dysfunction A retrospective analysis of the SOLVD trials. J Am Coll Cardiol 32: 695-703, 1998.","DOI":"10.1016\/S0735-1097(98)00297-6"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Piccini JP, Stevens SR, Chang YC, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patient with nonvalvular atrial fibrillation. Circulation 127: 224-232, 2013.","DOI":"10.1161\/CIRCULATIONAHA.112.107128"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Komatsu T, Sato Y, Ozawa M, et al. Relationship between CHADS2 score and efficacy of antiarrhythmic drug therapy in patients with paroxysmal atrial fibrillation. Circ J 77: 639-645, 2013.","DOI":"10.1253\/circj.CJ-12-0854"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Komatsu T, Tachibana H, Sato Y, et al. Relationship between CHA(2)DS(2)-VASc scores and ischemic stroke\/cardiovascular events in Japanese patients with paroxysmal atrial fibrillation not receiving anticoagulant therapy. J Cardiol 59: 321-328, 2012.","DOI":"10.1016\/j.jjcc.2012.01.003"},{"key":"6","unstructured":"6. Sopher SM, Camm AJ. Atrial fibrillation: maintenance of sinus rhythm versus rate control. Am J Cardiol 77: 24A-37A, 1996."},{"key":"7","unstructured":"7. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH2009). Hypertens Res 32: 3-107, 2009."},{"key":"8","unstructured":"8. Investigating Committee of Guideline for Diagnosis and Treatment of Hyperlipidemias: Guidelines for diagnosis and treatment of hyperlipidemia in adults. J Jpn Atheroscler 25: 1-34, 1997."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Komatsu T, Tachibana H, Sato Y, et al. Efficacy of amiodarone for preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation after cardioversion. Circ J 71: 46-51, 2007.","DOI":"10.1253\/circj.71.46"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Fuster V, Ryden LE, Cannom DS, et al. ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation: executive summary: A report of the American College\/American Heart Association Task Force on Practice guidelines and the European Society of Cardiology Committee for Practice guidelines and policy conferences developed in collaboration with the European heart Rhythm Association and the Heart Rhythm Society. Circulation 114: 700-752, 2006.","DOI":"10.1161\/CIRCULATIONAHA.106.177031"},{"key":"11","unstructured":"11. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33: 2719-2747, 2012."},{"key":"12","unstructured":"12. Kodama H, Aisawa Y, Inoue H, et al. (Report of Joint Research Group, Japanese Circulation Society): Guideline for drug treatment of arrhythmia. Circ J 68 (Suppl IV): 981-1053, 2004."},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22: 983-988, 1991.","DOI":"10.1161\/01.STR.22.8.983"},{"key":"14","unstructured":"14. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98: 476-484, 1995."},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. L\u00e9vy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 99: 3028-3035, 1999.","DOI":"10.1161\/01.CIR.99.23.3028"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290: 2685-2692, 2003.","DOI":"10.1001\/jama.290.20.2685"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association\/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37: 1583-1633, 2006.","DOI":"10.1161\/01.STR.0000223048.70103.F1"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Braunwald E, Antman EM, Beasley JW, et al. Guidelines for the management of patients with an increased risk for mortality. Circulation 102: 1193, 2000.","DOI":"10.1161\/01.CIR.102.10.1193"},{"key":"19","unstructured":"19. Phillippart R, Brunet-Bernard A, Clementy N, et al. Prognostic value of CHA2DS2-VASc score in patients with &apos;non-valvular atrial fibrillation&apos; and valvular heart disease: the Loire Valley Atrial Fibrillation Project. Eur Heart J 36: 1822-1830, 2015."},{"key":"20","unstructured":"20. Locatelli F, Pozzoni P, Tentori F, Del Vecchio L. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant 18 (Suppl 7): vii2-vii9, 2003."},{"key":"21","unstructured":"21. Pecotis-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome: the heart of the matter. Nephrol Dial Transplant 17 (Suppl 11): 28-31, 2002."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gusbeth-Tatomir P, Covic A. Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res 30: 97-107, 2007.","DOI":"10.1159\/000100905"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Satoh M, Fujimoto S, Haruna Y, et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 288: F1144-F1152, 2005.","DOI":"10.1152\/ajprenal.00221.2004"},{"key":"24","unstructured":"24. Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease:a competing risks modeling approach. J Am Soc Nephrol 16: 2449-2455, 2005."},{"key":"25","unstructured":"25. Yilmaz MI, Saglam M, Caglar K, et al. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47: 42-50, 2006."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nishiyama Y, Ueda M, Katsura K, et al. Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke. J Neurol Sci 290: 12-15, 2010.","DOI":"10.1016\/j.jns.2009.12.020"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kuwabara A, Satoh M, Tomita N, Sasaki T, Kashihara N. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 53: 2056-2065, 2010.","DOI":"10.1007\/s00125-010-1810-0"},{"key":"28","unstructured":"28. Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis : a viewpoint for linkage of albuminuria and cerebrocardiovascular risk. Hypertens Res 32: 115-121, 2009."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail 23: 71-76, 2001.","DOI":"10.1081\/JDI-100001285"},{"key":"30","unstructured":"30. Fabbian F, Catalano C, Lambertini D, et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol 54: 234-239, 2000."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Genovesi S, Pogliani D, Faini A, et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 46: 897-902, 2005.","DOI":"10.1053\/j.ajkd.2005.07.044"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Horio T, Iwashima Y, Kamide K, et al. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J Hypertens 28: 1738-1744, 2010.","DOI":"10.1097\/HJH.0b013e32833a7dfe"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Soliman EZ, Prineas RJ, Go AS, et al. Chronic kidney disease and prevalent atrial fibrillation. The Chronic Renal Insufficiency Cohort (CRIC). Am Heart J 159: 1102-1107, 2010.","DOI":"10.1016\/j.ahj.2010.03.027"},{"key":"34","unstructured":"34. Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 158: 629-636, 2009."},{"key":"35","unstructured":"35. Banerjee A, Fauchier L, Vourc&apos;h P, et al. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. J Am Coll Cardiol 61: 2079-2087, 2013."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Rold\u00e1n V, Marin F, Manzano-Fernandez S, et al. Does chronic kidney disease improve the predictive value of the CHADS<sub>2<\/sub> and CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost 109: 956-960, 2013.","DOI":"10.1160\/TH13-01-0054"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/21\/56_8914-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T22:32:47Z","timestamp":1570141967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/21\/56_8914-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":36,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8914-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}